Longer telomere length in patients with schizophrenia

Schizophrenia Research

Volumn 149, Issue 1-3, 2013, Pages 116-120

  Nieratschker, Vanessa ^a,b   Lahtinen, Jenni ^c   Meier, Sandra ^a   Strohmaier, Jana ^a   Frank, Josef ^a   Heinrich, Angela ^a   Breuer, René ^a   Witt, Stephanie H ^a   Nöthen, Markus M ^d,e   Rietschel, Marcella ^a   Hovatta, Iiris ^c,f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF BONN   (Germany)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Case control design; DNA extraction method; Schizophrenia; Severity; Subphenotype; Telomere length

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DISEASE SEVERITY; DNA EXTRACTION; ENDOPHENOTYPE; EPISODIC MEMORY; FEMALE; HIPPOCAMPUS; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; TELOMERE; TELOMERE LENGTH;

CASE-CONTROL DESIGN; CV; DEOXYRIBONUCLEIC ACID; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS FOURTH EDITION; DNA; DNA EXTRACTION METHOD; DOUBLE STRAND; DSDNA; DSM-IV; EDTA; ETHYLENEDIAMINETETRAACETIC; FAGERSTROM TEST OF NICOTINE DEPENDENCE; FNTD; HGB; INTER-ASSAY COEFFICIENT OF VARIATION; MICROLITER; NANOGRAMS; NANOMOLAR; NATIONAL GENOME RESEARCH NETWORK; NG; NGFN; NM; OPCRIT; OPERATIONAL CRITERIA CHECKLIST FOR PSYCHOTIC ILLNESS; QPCR; QUANTITATIVE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SCID; SCZ; SEVERITY; STRUCTURED CLINICAL INTERVIEW FOR DSM-IV AXIS I DISORDERS; SUBPHENOTYPE; TELOMERE LENGTH; Β-HEMOGLOBIN; ΜL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMMUNITY HEALTH PLANNING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; TELOMERE; YOUNG ADULT;

EID: 84881257932     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.06.043     Document Type: Article

References (66)

1. Adriano F., Caltagirone C., Spalletta G. Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 2012, 18(2):180-200.
2. Ahola K., Siren I., Kivimaki M., Ripatti S., Aromaa A., Lonnqvist J., Hovatta I. Work-related exhaustion and telomere length: a population-based study. PLoS One 2012, 7(7):e40186.
3. Aleman A., Hijman R., de Haan E.H., Kahn R.S. Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry 1999, 156(9):1358-1366.
4. Artandi S.E., DePinho R.A. Telomeres and telomerase in cancer. Carcinogenesis 2010, 31(1):9-18.
5. Babizhayev M.A., Yegorov Y.E. Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large population-based cohort under the effect of smoking duration. Fundam. Clin. Pharmacol. 2011, 25(4):425-442.
6. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106(6):661-673.
7. Broer L., Codd V., Nyholt D.R., Deelen J., Mangino M., Willemsen G., Albrecht E., Amin N., Beekman M., de Geus E.J., Henders A., Nelson C.P., Steves C.J., Wright M.J., de Craen A.J., Isaacs A., Matthews M., Moayyeri A., Montgomery G.W., Oostra B.A., Vink J.M., Spector T.D., Slagboom P.E., Martin N.G., Samani N.J., van Duijn C.M., Boomsma D.I. Meta-analysis of telomere length in 19,713 subjects reveals high heritability, stronger maternal inheritance and a paternal age effect. Eur. J. Hum. Genet. 2013, (in press). Electronic publication ahead of print.
8. Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., Samani N.J. White cell telomere length and risk of premature myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2003, 23(5):842-846.
9. Bushe C.J., Taylor M., Haukka J. Mortality in schizophrenia: a measurable clinical endpoint. J. Psychopharmacol. 2010, 24(4 Suppl.):17-25.
10. Butt H.Z., Atturu G., London N.J., Sayers R.D., Bown M.J. Telomere length dynamics in vascular disease: a review. Eur. J. Vasc. Endovasc. Surg. 2010, 40(1):17-26.
11. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002, 30(10):e47.
12. Codd V., Nelson C.P., Albrecht E., Mangino M., Deelen J., Buxton J.L., Hottenga J.J., Fischer K., Esko T., Surakka I., Broer L., Nyholt D.R., Mateo Leach I., Salo P., Hagg S., Matthews M.K., Palmen J., Norata G.D., O'Reilly P.F., Saleheen D., Amin N., Balmforth A.J., Beekman M., de Boer R.A., Bohringer S., Braund P.S., Burton P.R., Craen A.J., Denniff M., Dong Y., Douroudis K., Dubinina E., Eriksson J.G., Garlaschelli K., Guo D., Hartikainen A.L., Henders A.K., Houwing-Duistermaat J.J., Kananen L., Karssen L.C., Kettunen J., Klopp N., Lagou V., van Leeuwen E.M., Madden P.A., Magi R., Magnusson P.K., Mannisto S., McCarthy M.I., Medland S.E., Mihailov E., Montgomery G.W., Oostra B.A., Palotie A., Peters A., Pollard H., Pouta A., Prokopenko I., Ripatti S., Salomaa V., Suchiman H.E., Valdes A.M., Verweij N., Vinuela A., Wang X., Wichmann H.E., Widen E., Willemsen G., Wright M.J., Xia K., Xiao X., van Veldhuisen D.J., Catapano A.L., Tobin M.D., Hall A.S., Blakemore A.I., van Gilst W.H., Zhu H., Consortium C., Erdmann J., Reilly M.P., Kathiresan S., Schunkert H., Talmud P.J., Pedersen N.L., Perola M., Ouwehand W., Kaprio J., Martin N.G., van Duijn C.M., Hovatta I., Gieger C., Metspalu A., Boomsma D.I., Jarvelin M.R., Slagboom P.E., Thompson J.R., Spector T.D., van der Harst P., Samani N.J. Identification of seven loci affecting mean telomere length and their association with disease. Nat. Genet. 2013, 45(4):422-427.
13. Damjanovic A.K., Yang Y., Glaser R., Kiecolt-Glaser J.K., Nguyen H., Laskowski B., Zou Y., Beversdorf D.Q., Weng N.P. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J. Immunol. 2007, 179(6):4249-4254.
14. de Lange T. Protection of mammalian telomeres. Oncogene 2002, 21(4):532-540.
15. De Meyer T., Rietzschel E.R., De Buyzere M.L., Van Criekinge W., Bekaert S. Studying telomeres in a longitudinal population based study. Front. Biosci. 2008, 13:2960-2970.
16. Drury S.S., Theall K., Gleason M.M., Smyke A.T., De Vivo I., Wong J.Y., Fox N.A., Zeanah C.H., Nelson C.A. Telomere length and early severe social deprivation: linking early adversity and cellular aging. Mol. Psychiatry 2011, 17(7):719-727.
17. Eerola J., Kananen L., Manninen K., Hellstrom O., Tienari P.J., Hovatta I. No evidence for shorter leukocyte telomere length in Parkinson's disease patients. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65(11):1181-1184.
18. Eisenberg D.T., Hayes M.G., Kuzawa C.W. Delayed paternal age of reproduction in humans is associated with longer telomeres across two generations of descendants. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(26):10251-10256.
19. Entringer S., Epel E.S., Kumsta R., Lin J., Hellhammer D.H., Blackburn E.H., Wust S., Wadhwa P.D. Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(33):E513-E518.
20. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(49):17312-17315.
21. Fagerstrom K.O., Heatherton T.F., Kozlowski L.T. Nicotine addiction and its assessment. Ear Nose Throat J. 1990, 69(11):763-765.
22. Fernandez-Egea E., Bernardo M., Heaphy C.M., Griffith J.K., Parellada E., Esmatjes E., Conget I., Nguyen L., George V., Stoppler H., Kirkpatrick B. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr. Bull. 2009, 35(2):437-442.
23. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Disorders 1998, American Psychiatric Publishing, Arlington.
24. Fitzpatrick A.L., Kronmal R.A., Gardner J.P., Psaty B.M., Jenny N.S., Tracy R.P., Walston J., Kimura M., Aviv A. Leukocyte telomere length and cardiovascular disease in the Cardiovascular Health Study. Am. J. Epidemiol. 2007, 165(1):14-21.
25. Hartmann N., Boehner M., Groenen F., Kalb R. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress. Anxiety 2010, 27(12):1111-1116.
26. Heald A. Physical health in schizophrenia: a challenge for antipsychotic therapy. Eur. Psychiatry 2010, 25(Suppl. 2):S6-S11.
27. Hoefgen B., Schulze T.G., Ohlraun S., von Widdern O., Hofels S., Gross M., Heidmann V., Kovalenko S., Eckermann A., Kolsch H., Metten M., Zobel A., Becker T., Nothen M.M., Propping P., Heun R., Maier W., Rietschel M. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol. Psychiatry 2005, 57(3):247-251.
28. Hoen P.W., de Jonge P., Na B.Y., Farzaneh-Far R., Epel E., Lin J., Blackburn E., Whooley M.A. Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study. Psychosom. Med. 2011, 73(7):541-547.
29. Hoen P.W., Rosmalen J.G., Schoevers R.A., Huzen J., van der Harst P., de Jonge P. Association between anxiety but not depressive disorders and leukocyte telomere length after 2years of follow-up in a population-based sample. Psychol. Med. 2012, 1-9.
30. Houben J.M., Moonen H.J., van Schooten F.J., Hageman G.J. Telomere length assessment: biomarker of chronic oxidative stress?. Free Radic. Biol. Med. 2008, 44(3):235-246.
31. Humphreys J., Epel E.S., Cooper B.A., Lin J., Blackburn E.H., Lee K.A. Telomere shortening in formerly abused and never abused women. Biol. Res. Nurs. 2012, 14(2):115-123.
32. Iwama H., Ohyashiki K., Ohyashiki J.H., Hayashi S., Yahata N., Ando K., Toyama K., Hoshika A., Takasaki M., Mori M., Shay J.W. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum. Genet. 1998, 102(4):397-402.
33. Kananen L., Surakka I., Pirkola S., Suvisaari J., Lonnqvist J., Peltonen L., Ripatti S., Hovatta I. Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One 2010, 5(5):e10826.
34. Kao H.T., Cawthon R.M., Delisi L.E., Bertisch H.C., Ji F., Gordon D., Li P., Benedict M.M., Greenberg W.M., Porton B. Rapid telomere erosion in schizophrenia. Mol. Psychiatry 2008, 13(2):118-119.
35. Kiecolt-Glaser J.K., Gouin J.P., Weng N.P., Malarkey W.B., Beversdorf D.Q., Glaser R. Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom. Med. 2011, 73(1):16-22.
36. Kimura M., Cherkas L.F., Kato B.S., Demissie S., Hjelmborg J.B., Brimacombe M., Cupples A., Hunkin J.L., Gardner J.P., Lu X., Cao X., Sastrasinh M., Province M.A., Hunt S.C., Christensen K., Levy D., Spector T.D., Aviv A. Offspring's leukocyte telomere length, paternal age, and telomere elongation in sperm. PLoS Genet. 2008, 4(2):e37.
37. Kühner C. Fragebogen zur Depressionsdiagnostik nach DSM-IV (FDD-DSM-IV) 1997, Hogrefe, Göttingen.
38. Laursen T.M., Munk-Olsen T., Agerbo E., Gasse C., Mortensen P.B. Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch. Gen. Psychiatry 2009, 66(7):713-720.
39. Lung F.W., Chen N.C., Shu B.C. Genetic pathway of major depressive disorder in shortening telomeric length. Psychiatr. Genet. 2007, 17(3):195-199.
40. Malan S., Hemmings S., Kidd M., Martin L., Seedat S. Investigation of telomere length and psychological stress in rape victims. Depress. Anxiety 2011, 28(12):1081-1085.
41. Mansour H., Chowdari K., Fathi W., Elassy M., Ibrahim I., Wood J., Bamne M., Tobar S., Yassin A., Salah H., Elsayed H., Eissa A., El-Boraie H., Ibrahim N.E., Elsayed M., El-Bahaei W., Gomaa Z., El-Chennawi F., Nimgaonkar V.L. Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia?. Psychiatry Res. 2011, 188(1):129-132.
42. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 1991, 48(8):764-770.
43. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16(3):1215.
44. Njajou O.T., Cawthon R.M., Damcott C.M., Wu S.H., Ott S., Garant M.J., Blackburn E.H., Mitchell B.D., Shuldiner A.R., Hsueh W.C. Telomere length is paternally inherited and is associated with parental lifespan. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(29):12135-12139.
45. Nordfjall K., Svenson U., Norrback K.F., Adolfsson R., Roos G. Large-scale parent-child comparison confirms a strong paternal influence on telomere length. Eur. J. Hum. Genet. 2010, 18(3):385-389.
46. O'Donovan A., Epel E., Lin J., Wolkowitz O., Cohen B., Maguen S., Metzler T., Lenoci M., Blackburn E., Neylan T.C. Childhood trauma associated with short leukocyte telomere length in posttraumatic stress disorder. Biol. Psychiatry 2011, 70(5):465-471.
47. Perrin M.C., Brown A.S., Malaspina D. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. Schizophr. Bull. 2007, 33(6):1270-1273.
48. Ragland J.D., Laird A.R., Ranganath C., Blumenfeld R.S., Gonzales S.M., Glahn D.C. Prefrontal activation deficits during episodic memory in schizophrenia. Am. J. Psychiatry 2009, 166(8):863-874.
49. Rampazzo E., Bertorelle R., Serra L., Terrin L., Candiotto C., Pucciarelli S., Del Bianco P., Nitti D., De Rossi A. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br. J. Cancer 2010, 102(8):1300-1305.
50. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch. Gen. Psychiatry 2007, 64(10):1123-1131.
51. Saliques S., Zeller M., Lorin J., Lorgis L., Teyssier J.R., Cottin Y., Rochette L., Vergely C. Telomere length and cardiovascular disease. Arch. Cardiovasc. Dis. 2010, 103(8-9):454-459.
52. Sampson M.J., Hughes D.A. Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes. Diabetologia 2006, 49(8):1726-1731.
53. Savolainen K., Raikkonen K., Kananen L., Kajantie E., Hovatta I., Lahti M., Lahti J., Pesonen A.K., Heinonen K., Eriksson J.G. History of mental disorders and leukocyte telomere length in late adulthood: the Helsinki Birth Cohort Study (HBCS). J. Psychiatr. Res. 2012, 46(10):1346-1353.
54. Shalev I., Moffitt T.E., Sugden K., Williams B., Houts R.M., Danese A., Mill J., Arseneault L., Caspi A. Exposure to violence during childhood is associated with telomere erosion from 5 to 10years of age: a longitudinal study. Mol. Psychiatry 2012, 18(5):576-581.
55. Sibille K.T., Langaee T., Burkley B., Gong Y., Glover T.L., King C., Riley J.L., Leeuwenburgh C., Staud R., Bradley L.A., Fillingim R.B. Chronic pain, perceived stress, and cellular aging: an exploratory study. Mol. Pain 2012, 8:12.
56. Simon N.M., Smoller J.W., McNamara K.L., Maser R.S., Zalta A.K., Pollack M.H., Nierenberg A.A., Fava M., Wong K.K. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol. Psychiatry 2006, 60(5):432-435.
57. Slagboom P.E., Droog S., Boomsma D.I. Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet. 1994, 55(5):876-882.
58. Tyrka A.R., Price L.H., Kao H.T., Porton B., Marsella S.A., Carpenter L.L. Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging. Biol. Psychiatry 2010, 67(6):531-534.
59. Uchino B.N., Cawthon R.M., Smith T.W., Light K.C., McKenzie J., Carlisle M., Gunn H., Birmingham W., Bowen K. Social relationships and health: is feeling positive, negative, or both (ambivalent) about your social ties related to telomeres?. Health Psychol. 2012, 31(6):789-796.
60. Unryn B.M., Cook L.S., Riabowol K.T. Paternal age is positively linked to telomere length of children. Aging Cell 2005, 4(2):97-101.
61. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27(7):339-344.
62. Wikgren M., Karlsson T., Lind J., Nilbrink T., Hultdin J., Sleegers K., Van Broeckhoven C., Roos G., Nilsson L.G., Nyberg L., Adolfsson R., Norrback K.F. Longer leukocyte telomere length is associated with smaller hippocampal volume among non-demented APOE epsilon3/epsilon3 subjects. PLoS One 2012, 7(4):e34292.
63. Wikgren M., Karlsson T., Nilbrink T., Nordfjall K., Hultdin J., Sleegers K., Van Broeckhoven C., Nyberg L., Roos G., Nilsson L.G., Adolfsson R., Norrback K.F. APOE epsilon4 is associated with longer telomeres, and longer telomeres among epsilon4 carriers predicts worse episodic memory. Neurobiol. Aging 2012, 33(2):335-344.
64. Wolkowitz O.M., Mellon S.H., Epel E.S., Lin J., Dhabhar F.S., Su Y., Reus V.I., Rosser R., Burke H.M., Kupferman E., Compagnone M., Nelson J.C., Blackburn E.H. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress - preliminary findings. PLoS One 2011, 6(3):e17837.
65. Yu W.Y., Chang H.W., Lin C.H., Cho C.L. Short telomeres in patients with chronic schizophrenia who show a poor response to treatment. J. Psychiatry Neurosci. 2008, 33(3):244-247.
66. Zimmerman M., Coryell W., Corenthal C., Wilson S. A self-report scale to diagnose major depressive disorder. Arch. Gen. Psychiatry 1986, 43(11):1076-1081.